These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1694860)

  • 21. Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death.
    Qamar T; Levy RA; Sammaritano L; Gharavi AE; Lockshin MD
    Arthritis Rheum; 1990 Apr; 33(4):501-4. PubMed ID: 2109614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies.
    Laroche P; Berard M; Rouquette AM; Desgruelle C; Boffa MC
    Am J Clin Pathol; 1996 Oct; 106(4):549-54. PubMed ID: 8853046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis.
    Levy RA; Gharavi AE; Sammaritano LR; Habina L; Qamar T; Lockshin MD
    J Rheumatol; 1990 Aug; 17(8):1036-41. PubMed ID: 2120437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid cofactor.
    Gharavi AE
    Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors.
    Pérez-Vázquez ME; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1992 Apr; 92(4):357-62. PubMed ID: 1558081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of anti-phospholipid antibody specificities.
    Gilman-Sachs A; Lubinski J; Beer AE; Brend S; Beaman KD
    J Clin Lab Immunol; 1991 Jun; 35(2):83-8. PubMed ID: 1668762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
    Hörkkö S; Miller E; Dudl E; Reaven P; Curtiss LK; Zvaifler NJ; Terkeltaub R; Pierangeli SS; Branch DW; Palinski W; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):815-25. PubMed ID: 8698874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ELISA using Thrombofax is useful to verify antiphospholipid antibodies.
    Staub HL; Khamashta MA; Chahade WH; Hughes GR
    Thromb Res; 1990 Jun; 58(5):533-4. PubMed ID: 2114672
    [No Abstract]   [Full Text] [Related]  

  • 30. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA.
    Hasselaar P; Triplett DA; LaRue A; Derksen RH; Blokzijl L; de Groot PG; Wagenknecht DR; McIntyre JA
    J Rheumatol; 1990 Feb; 17(2):186-91. PubMed ID: 2099746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
    Raby A; Moffat K; Crowther M
    Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-phospholipid antibodies in the mercuric chloride treated brown Norway rat.
    Marriott JB; Qasim F; Oliveira DB
    J Autoimmun; 1994 Aug; 7(4):457-67. PubMed ID: 7980848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
    Wagenknecht DR; McIntyre JA
    Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat-labile serum inhibitor of anti-phospholipid antibody binding in ELISA.
    Cheng HM; Phuah EB
    Immunol Lett; 1989 Oct; 22(4):263-6. PubMed ID: 2628284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibody syndrome.
    Lockshin MD
    JAMA; 1992 Sep; 268(11):1451-3. PubMed ID: 1512915
    [No Abstract]   [Full Text] [Related]  

  • 38. Crossreactivity of antiphospholipid antibodies.
    Harris EN; Gharavi AE; Loizou S; Derue G; Chan JK; Patel BM; Mackworth-Young CG; Bunn CC; Hughes GR
    J Clin Lab Immunol; 1985 Jan; 16(1):1-6. PubMed ID: 3981615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies in syphilis.
    Santiago MB; Stellin R; Gaburo Júnior N; Bueno C; Viana VS; Cossermelli W; de-Oliveira RM
    Braz J Med Biol Res; 1990; 23(5):397-402. PubMed ID: 2095288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The beta-2-glycoprotein I and antiphospholipid antibodies.
    Shoenfeld Y; Meroni PL
    Clin Exp Rheumatol; 1992; 10(2):205-9. PubMed ID: 1505119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.